ストックスクリーナーアプリを入手
462.60
1.41%
-6.61
アフターアワーズ：
463.64
1.04
+0.22%
前日終値:
$469.21
開ける：
$466.98
24時間の取引高:
1.82M
Relative Volume:
0.82
時価総額：
$171.91B
収益：
$45.20B
当期純損益:
$6.87B
株価収益率:
25.43
EPS:
18.1888
ネットキャッシュフロー:
$6.75B
1週間 パフォーマンス:
-1.16%
1か月 パフォーマンス:
-5.87%
6か月 パフォーマンス:
-18.16%
1年 パフォーマンス:
+9.22%
1日の値動き範囲:
$461.90
$470.39
1週間の範囲:
$461.00
$481.83
52週間の値動き範囲:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, NTRA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
462.60 | 174.37B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.04 | 123.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
563.12 | 45.07B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.18 | 32.36B | 7.07B | 1.29B | 993.00M | 4.5355 |
NTRA
Natera Inc
|
211.56 | 29.60B | 2.31B | -208.16M | 76.11M | -1.5366 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | 開始されました | DZ Bank | Buy |
| 2025-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2025-12-09 | 開始されました | Goldman | Buy |
| 2025-12-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-12-01 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-09-11 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 開始されました | William Blair | Outperform |
| 2025-07-24 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Thermo Fisher Scientific Introduces Gibco CTS DynaXS Single Use Bioreactor - Contract Pharma
International Markets and Thermo Fisher (TMO): A Deep Dive for Investors - Yahoo Finance
Thermo Fisher Introduces Gibco CTS DynaXS Single Use Bioreactor For Scalable Cell Therapy Manufacturing - BioPharma APAC
Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing - FinancialContent
What Is Thermo Fisher Scientific Inc.'s (NYSE:TMO) Share Price Doing? - Yahoo Finance
Thermo Fisher's $1.08B Microbiology Sell-Off: A Procurement and Operations Briefing for Lab Managers - Lab Manager
Sandro Wealth Management LLC Makes New $2.09 Million Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
PFA Pension Forsikringsaktieselskab Purchases New Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Q1 2026 Financial Results and SEC 10-Q Filing Summary - Minichart
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Argus Adjusts Price Target on Thermo Fisher Scientific to $560 From $610 - marketscreener.com
Billionaire Investor Takes New Stake In Thermo Fisher Scientific - Yahoo Finance
Thermo Fisher (NYSE: TMO) grows Q1 revenue and closes $9.1B Clario deal - Stock Titan
Thermo Fisher Scientific Inc. $TMO Shares Sold by Danica Pension Livsforsikringsaktieselskab - MarketBeat
How Investors Are Reacting To Thermo Fisher Scientific (TMO) Expanding Its U.S. Bioprocess Design Center - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Argus Cuts Price Target on Thermo Fisher Scientific to $560 From $610 - marketscreener.com
Vanguard (NYSE: TMO) reports 28.0M shares of Thermo Fisher, 7.53% stake - Stock Titan
Thermo Fisher Scientific opens bioprocess design center in Massachusetts - chemengonline.com
Soil Testing Equipment Market Size, Share & Growth Outlook - openPR.com
Thermo Fisher Scientific Agrees to Divest Its Microbiology Business to Astorg - ChemAnalyst
PowerFlex thermal cycler boosts PCR flexibility & speed - SelectScience
Molecular Quality Controls Market | THERMO FISHER SCIENTIFIC, INC, Qnostics, Zeptometrix Corporation etc. - openPR.com
Insider Sell: Gianluca Pettiti Sells Shares of Thermo Fisher Sci - GuruFocus
Thermo Fisher Scientific Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
Thermo Fisher Scientific president & COO sells $185,064 in stock - Investing.com
Thermo Fisher Scientific president & COO sells $185,064 in stock By Investing.com - Investing.com UK
Thermo Fisher Scientific (NYSE:TMO) COO Sells $185,064.00 in Stock - MarketBeat
Thermo Fisher (NYSE: TMO) COO executes 400-share Rule 10b5-1 sale - Stock Titan
Thermo Fisher Scientific to sell its microbiology business as Astorg - chemengonline.com
Thermo Fisher Scientific launches applied Biosystems PowerFlex Thermal Cycler - Med-Tech Insights
Thermo Fisher Scientific, SHL Medical Collaborate on Integrated Drug-Device Solutions - Medical Product Outsourcing
Do You Believe in The Long-Term Growth Outlook of Thermo Fisher Scientific (TMO)? - Insider Monkey
Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies - BioSpace
Thermo Fisher Scientific to Host Investor DayApril 28, 2026 - BioSpace
Thermo Fisher to Sell Microbiology Business to Astorg - WSJ
Thermo Fisher opens Plainville design center amid $2B push for U.S. manufacturing - The Business Journals
Thermo Fisher sells microbiology business for $1B - BioWorld News
Thermo Fisher agrees to sell microbiology business to Astorg in $1bn deal - Medical Device Network
Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of - PharmiWeb.com
Thermo Fisher inks $1.1B deal to sell microbiology unit to Astorg - MedTech Dive
Thermo Fisher Scientific Opens Flagship U.S. Bioprocess Design Center in MA - Contract Pharma
Thermo Fisher Stock Fell After Q1 2026 Earnings. Is TMO a Buy? - TIKR.com
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg - Lelezard
Medical Refrigerators Market Competitive Analysis to 2028 | - openPR.com
Thermo Fisher drops despite Q1 beat, guidance hike - MSN
Thermo Fisher sells microbiology biz to Astorg for $1.075 B - BioSpectrum Asia
Thermo Fisher to divest microbiology business in $1.07 billion deal with PE firm Astorg - DOTmed
Thermo Fisher sells microbiology business to private equity firm for $1B - The Business Journals
Thermo Fisher to sell microbiology business to PE firm Astorg for over $1 billion - MSN
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
0.63%
2.06%
大文字化:
|
ボリューム (24 時間):